Cysteine 98 in CYP3A4 contributes to conformational integrity required for P450 interaction with CYP reductase

被引:12
|
作者
Wen, Bo
Lampe, Jed N.
Roberts, Arthur G.
Atkins, William M.
Rodrigues, A. David
Nelson, Sidney D.
机构
[1] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA
[2] Bristol Myers Squibb Co, Dept Metab & Pharmacokinet, Princeton, NJ 08543 USA
关键词
photoaffinity labeling; cytochrome P450 3A4; conformational integrity;
D O I
10.1016/j.abb.2006.08.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previously human cytochrome P450 3A4 was efficiently and specifically photolabeled by the photoaffinity ligand lapachenole. One of the modification sites was identified as cysteine 98 in the B-C loop region of the protein [B. Wen, C.E. Doneanu, C.A. Gartner, A.G. Roberts, W.M. Atkins, S.D. Nelson, Biochemistry 44 (2005) 1833-1845]. Loss of CO binding capacity and subsequent decrease of catalytic activity were observed in the labeled CYP3A4, which suggested that aromatic substitution on residue 98 triggered a critical conformational change and subsequent loss of enzyme activity. To test this hypothesis, C98A, C98S, C98F, and C98W mutants were generated by site-directed mutagenesis and expressed functionally as oligohistidine-tagged proteins. Unlike the mono-adduction observed in the wildtype protein, simultaneous multiple adductions occurred when C 98F and C98W were photolabeled under the same conditions as the wild-type enzyme, indicating a substantial conformational change in these two mutants compared with the wild-type protein. Kinetic analysis revealed that the C98W mutant had a drastic 16-fold decrease in catalytic efficiency (V-max/K-m) for 1'-OH midazolam formation, and about an 8-fold decrease in catalytic efficiency (V-max/K-m) for 4-OH midazolam formation, while the C98A and C98S mutants retained the same enzyme activity as the wild-type enzyme. Photolabeling of C98A and C98S with lapachenole resulted in monoadduction of only Cys-468, in contrast to the labeling of Cys-98 in wild-type CYPA4,demonstrating the marked selectivity of this photoaffinity ligand for cysteine residues. The slight increases in the midazolam binding constants (K-s) in these mutants suggested negligible perturbation of the heme environment. Further activity studies using different P450:reductase ratios suggested that the affinity of P450 to reductase was significantly decreased in the C98W mutant, but not in the,,C98A and C98S mutants. In addition, the C98W mutant exhibited a 41% decrease in the maximum electron flow rate between P450 and reductase as measured by reduced nicotinamide adenine dinucleotide phosphate consumption at a saturating reductase concentration. In conclusion, our data strongly suggest that cysteine 98 in the B-C loop region significantly contributes to conformational integrity and catalytic activity of CYP3A4, and that this residue or residues nearby might be involved in an interaction with P450 reductase. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:42 / 54
页数:13
相关论文
共 50 条
  • [41] A Measurement Method for Cytochrome P450 3A4 (CYP3A4)-mediated Oxidation of Cholesterol in Lipid Membranes
    Shoji, Atsushi
    Miki, Haruka
    Kikkawa, Mikiko
    Yamamoto, Miyu
    Moriiwa, Yukiko
    Morioka, Kazuhiro
    Yanagida, Akio
    SENSORS AND MATERIALS, 2022, 34 (03) : 951 - 960
  • [42] Evaluation of Luciferin-Isopropyl Acetal as a CYP3A4 Substrate for Human Hepatocytes: Effects of Organic Solvents, Cytochrome P450 (P450) Inhibitors, and P450 Inducers
    Li, Albert P.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (08) : 1598 - 1603
  • [43] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Danek, Przemyslaw J.
    Basinska-Ziobron, Agnieszka
    Wojcikowski, Jacek
    Daniel, Wladyslawa A.
    PHARMACOLOGICAL REPORTS, 2021, 73 (01) : 303 - 308
  • [44] Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes
    Natsui, Kiyohi
    Mizuno, Yoshiko
    Tani, Naoko
    Yabuki, Masashi
    Komuro, Setsuko
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2007, 32 (04) : 233 - 240
  • [45] Effects of cytostatic drugs on activity of the cytochrome P450 isoform CYP3A4 in human liver microsomes
    RaoSchymanski, RA
    Bocker, R
    Barthold, B
    Muller, A
    Fuhr, U
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 465 - 465
  • [46] Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
    Agrawal, Vishal
    Choi, Ji Ha
    Giacomini, Kathleen M.
    Miller, Walter L.
    PHARMACOGENETICS AND GENOMICS, 2010, 20 (10): : 611 - 618
  • [47] Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4
    Przemysław J. Danek
    Agnieszka Basińska-Ziobroń
    Jacek Wójcikowski
    Władysława A. Daniel
    Pharmacological Reports, 2021, 73 : 303 - 308
  • [48] Mechanism of Drug-Drug Interactions Mediated by Human Cytochrome P450 CYP3A4 Monomer
    Denisov, Ilia G.
    Grinkova, Yelena V.
    Baylon, Javier L.
    Tajkhorshid, Emad
    Sligar, Stephen G.
    BIOCHEMISTRY, 2015, 54 (13) : 2227 - 2239
  • [49] The effects of type II binding on metabolic stability and binding affinity in cytochrome P450 CYP3A4
    Peng, Chi-Chi
    Pearson, Josh T.
    Rock, Dan A.
    Joswig-Jones, Carolyn A.
    Jones, Jeffrey P.
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2010, 497 (1-2) : 68 - 81
  • [50] 慢性肝胆疾患P450同工酶CYP3A4表达的改变
    杨立群
    曹云飞
    俞卫锋
    李慎菁
    第二军医大学学报, 2002, (04) : 407 - 409